arrow
F

Frédéric Charlotte

Hôpital Pitié-Salpêtrière
H指数:86
被引数:3.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CBL Variants in Suspected Histiocytic Neoplasms: A Retrospective Study of 11 Cases

<i>CBL</i> 变体在疑似组织细胞性肿瘤中的研究:11例回顾性研究

2026-09-200
PRE
ALKATI drives nuclear ALK expression in histiocytic neoplasms without ALK fusions

ALKATI 在不携带 ALK 融合的组织细胞肿瘤中驱动核 ALK 的表达

2025-12-300
PRE
Simple, Rapid, Reproducible and Biomarker-Validated Clinical Grading System for Murine Models of Xenogeneic Graft-Versus-Host Disease

简单、快速、可重复且经生物标志物验证的临床分级系统,用于异种移植物抗宿主病的小鼠模型

2025-06-010
PRE
Expression of an interleukin-2 partial agonist enhances regulatory T cell persistence and efficacy in mouse autoimmune models

白细胞介素-2部分激动剂的表达到增强调节性T细胞在鼠类自身免疫模型中的持久性和功效

2025-05-270
OAAI
Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

三条被忽视的STARD标准降低了代谢功能障碍相关脂肪性肝病(MASLD)中肝纤维化生物标志物FibroTest-T2D的不确定性。

2025-05-150
OA
Liver Disease Complicating Familial Mediterranean Fever: A Study on 66 Patients Out of 533 Adult From the JIR Cohort
2025-01-101
PRE
Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)
2024-07-011
OAAI
Epstein-Barr virus and immune status imprint the immunogenomics of non-Hodgkin lymphomas occurring in immune-suppressed environments
2024-06-061
OAAI
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
2023-12-1414
OAAI